CNBC.com's News Now

Wednesday, Feb. 13, 2008 1. Clemens Under Oath: Roger Clemens and his trainer are grilled on Capitol Hill, and CNBC's Darren Rovell follows the story. 2. Buffett's Bond Offer: Perspectives on Warren Buffett's plan to help troubled bond insurers, with Wilbur Ross, Jr., WL Ross & Co. chairman/CEO and CNBC's Becky Quick. 3. New Rush to Re-Fi? President Bush's signature on the economic stimulus bill could trigger a new rush of mortgage refinancing, reports CNBC's Diana Olick. 4. Paulson on the Stimulus Plan: Treasury Secretary Henry Paulson discusses the economic stimulus plan, signed today by President Bush. 5. Stop Trading, Listen to Cramer! Mad Money's Jim Cramer shares his stock picks with CNBC's Erin Burnett. Congress And Clemens: You Can't Beat This For TV Drama It was Roger Clemens and Brian McNamee sitting at the same table today in front of a Congressional hearing. One was denying and the other was accusing steroid use. Darren Rovell blogs about what he calls one of the most exciting dramas on TV.Click here to view posting. BIG THREE ON THE HILL: Fed Chief Ben Bernanke, Treasury Secretary Hank Paulson and SEC Chairman Christopher Cox will appear before the Senate Banking Committee Thursday morning. All eyes will be on the committee room... and Steve Liesman will provide instant analysis. BRIGHT SPOTS ON THE REAL ESTATE MAP: The National Association of Realtors will release fourth quarter metro home prices at 10am. U.S. real estate is still struggling to pull itself from its woes. But, home prices are local. What's hot? What's not? Diana Olick reports. TRIPLE-DUTY DRUG: The New England Journal of Medicine releases a study asserting Genentech/Biogen's drug Rituxan is also effective in treating multiple sclerosis. Rituxan's is currently approving for combating non-Hodgkin's lymphoma and rheumatoid arthritis, and now jumps from a double-duty to a triple-duty drug. Mike Huckman looks at the impact of the news for Genentech and Biogen Idec shareholders. FOR LOVE OF MONEY: Valentine's Day is the major first-quarter holiday and the first indication of how strong consumer buying is in 2008. The $6 billion dollar flower industry and its major players (including 1-800-flowers, FTD, Teleflora, et al) are already worried that consumers will cut back on the luxury of flower orders this Valentine's Day. Have rate cuts and the government's economic rescue plan revived consumer psychology and willingness to spend? Last year, snow storms and bad weather hurt deliveries. This holiday, will Mother Nature wilt or revive the already struggling delivery business? Portfolio Watchlist Insider Trends Financial Glossary Stock Screeners Fund Screeners Earnings Screeners Watch CNBC LIVE on your computer. Click here for more information.

To unsubscribe to this email click here If this e-mail was forwarded to you and you would like to subscribe to CNBC.com's News Now mailing, please click here